MLB player’s myocarditis puts spotlight on potential cardiovascular complications of COVID-19

Eduardo Rodriguez, a 27-year-old pitcher for the Boston Red Sox, has confirmed that he is currently suffering from myocarditis related to a recent COVID-19 diagnosis. He has been shut down from all baseball-related activities for at least one full week.

The news comes just days after Major League Baseball (MLB) began its pandemic-shortened season. It also highlights the potential seriousness of the various cardiovascular complications associated with the virus. “What is myocarditis?” may be an especially common search term in the days, and weeks, ahead.

Rodriguez spoke with Rob Bradford of WEEI about the ongoing situation.

“When I feel the symptoms, back when I got COVID, I felt it all,” he said, as quoted by Bradford. “I felt all the symptoms and everything. Right now, I don’t feel all the symptoms. I got surprised when I got that from my heart because I don’t feel any symptoms from that, I didn’t feel anything from my chest, nothing like that.”

Numerous MLB players have already been diagnosed with COVID-19 and made a healthy comeback. One team, the Miami Marlins, is currently struggling with a clubhouse outbreak—the team had to postpone two games as a result.

Click the link below to read the full report from WEEI.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.